# US 2023/0263753 A1 · Soft capsule comprising b-hydroxybutyric acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0263753 A1
- Document ID: US20230263753A1
- Status: Published application
- Kind: A1
- Application number: 18/172,020
- Filed: 2023-02-21
- Published: 2023-08-24
- Earliest claimed: 2022-03-21
- Assignees: Nanjing Nutrabuilding Bio-Tech Co., Ltd.
- Applicants: Nanjing Nutrabuilding Bio-Tech Co., Ltd.
- Inventors: Long JIANG; Xuyang SUN; Ronghua YI; Shawn WELLS; Kylin LIAO
- Web page: https://patentgrep.com/patent/US20230263753A1

## CPC

- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 9/4816: {Wall or shell material}
- A61K 9/4825: {Proteins, e.g. gelatin (gelatin capsule shells with substantial amounts of other macromolecular substances A61K9/4816)}
- A61K 9/4833: {Encapsulating processes; Filling of capsules (mechanical aspects A61J3/07)}
- A61K 9/4858: {Organic compounds}
- A61K 9/4866: {Organic macromolecular compounds}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Among others, this invention provides a soft capsule comprising β-hydroxybutyric acid (BHB) or a pharmaceutically acceptable salt, ester, liposome, or mixture thereof as active ingredient, as well as method of making such soft capsule.

## Claims

### Claim 1

A soft capsule comprising an outer shell and a fill material within the outer shell, wherein the outer shell comprises a gelatin or a plant-based material; the fill material comprises an active ingredient which is β-hydroxybutyric acid (BHB), a pharmaceutically acceptable salt, ester, liposome, or a mixture thereof.

### Claim 2 (depends on 1)

The soft capsule of claim 1, wherein the outer shell further comprises a humectant and water, the humectant is selected from polyethylene glycol 200, polyethylene glycol 400, polyethylene glycol 600, polyethylene glycol 800, polyethylene glycol 1000, polyethylene glycol 1500, polyethylene glycol 2000, glycerin, sorbitol, polydextrose, maltitol, or a mixture thereof.

### Claim 3 (depends on 2)

The soft capsule of claim 2, wherein the humectant is selected from glycerin, sorbitol or polyethylene glycol 400.

### Claim 4 (depends on 2)

The soft capsule of claim 2, wherein the active ingredient has a mass percentage ranging from 20% to 80% of the total weight of the capsule; the gelatin or plant-based material has a mass percentage ranging from 10% to 40% of the total weight of the capsule; the humectant has a mass percentage ranging from 2% to 20% of the total weight of the capsule; the water has a mass percentage ranging from 2% to 20% of the total weight of the capsule.

### Claim 5 (depends on 1)

The soft capsule of claim 1, wherein the gelatin has a bloom strength of 100-300; the plant-based material is starch or colloid.

### Claim 6 (depends on 5)

The soft capsule of claim 5, wherein the starch is selected from oxidized starch, starch dispersion, starch derivatives, starch hydrolysate, wet heat-treated starch, acid-treated starch, or a mixture thereof; the colloid is selected from carrageenan, mannan gum, xanthan gum, alginate, or a mixture thereof.

### Claim 7 (depends on 1)

The soft capsule of claim 1, wherein the pharmaceutically acceptable salt, ester is selected from BHB potassium salt, BHB sodium salt, BHB calcium salt, BHB magnesium salt, BHB calcium magnesium salt, BHB triglyceride.

### Claim 8 (depends on 7)

The soft capsule of claim 7, wherein the pharmaceutically acceptable salt, ester is selected from BHB sodium salt, BHB calcium magnesium salt, BHB triglyceride.

### Claim 9 (depends on 1)

The soft capsule of claim 1, wherein the fill material further comprises a suspending agent, the suspending agent is selected from polyethylene glycol 200, polyethylene glycol 400, polyethylene glycol 600, polyethylene glycol 800, polyethylene glycol 1000, polyethylene glycol 1500, polyethylene glycol 2000, glycerin, sorbitol, polydextrose, maltitol and a mixture thereof.

### Claim 10 (depends on 9)

The soft capsule of claim 9, wherein the suspending agent is glycerin, polyethylene glycol 400 or sorbitol.

### Claim 11 (depends on 9)

The soft capsule of claim 9, wherein the suspending agent has a mass percentage ranging from 3% to 45% of the total weight of the capsule.

### Claim 12 (depends on 1)

The soft capsule of claim 1, wherein the fill material is in the form of solution, suspension, or paste.

### Claim 13 (depends on 12)

The soft capsule of claim 12, wherein the fill material is in the form of suspension.

### Claim 14 (depends on 1)

The soft capsule of claim 1, wherein the weight of the fill material ranges from 80 to 2500 mg, and total weight of the soft capsule ranges from 120 to 3750 mg.

### Claim 15 (depends on 1)

A method for preparing a soft capsule of claim 1, comprising the steps of (a) preparing β-hydroxybutyric acid (BHB), or a pharmaceutically acceptable salt, ester, liposome or mixture thereof, to form a fill composition; (b) preparing and formulating an outer shell using gelatin or a plant-based material; and (c) encapsulating the fill material into the outer shell.

### Claim 16 (depends on 15)

The method of claim 15, further comprising a step of shaping, drying, quality inspection, packaging, or storage.

### Claim 17 (depends on 15)

The method of claim 15, wherein step (a) comprises mixing the BHB or pharmaceutically acceptable salt with a suspending agent together, heating the mixture to a temperature of 35-60° C. and stirring, to form a homogenous mixture; or heating the pharmaceutically acceptable ester or liposome to a temperature of 35-60° C. and stirring.

### Claim 18 (depends on 15)

The method of claim 15, wherein step (b) comprises mixing the gelatin or plant-based material with a humectant and water together, stirring and heated to 50-100° C., de-aerating and filtering, to formulate an outer shell liquid.
